A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC
Beijing Cancer Prevention & Treatment Society · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022